Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113752195> ?p ?o ?g. }
- W2113752195 abstract "Human acute myeloid leukemia (AML) originates from rare leukemia stem cells (LSCs). Because these chemotherapy-resistant LSCs are thought to underlie disease relapse, effective therapeutic strategies specifically targeting these cells may be beneficial. Here, we report identification of a primary human LSC gene signature and functional characterization of human LSC-specific molecules in vivo in a mouse xenotransplantation model. In 32 of 61 (53%) patients with AML, either CD32 or CD25 or both were highly expressed in LSCs. CD32- or CD25-positive LSCs could initiate AML and were cell cycle-quiescent and chemotherapy-resistant in vivo. Normal human hematopoietic stem cells depleted of CD32- and CD25-positive cells maintained long-term multilineage hematopoietic reconstitution capacity in vivo, indicating the potential safety of treatments targeting these molecules. In addition to CD32 and CD25, quiescent LSCs within the bone marrow niche also expressed the transcription factor WT1 and the kinase HCK. These molecules are also promising targets for LSC-specific therapy." @default.
- W2113752195 created "2016-06-24" @default.
- W2113752195 creator A5010422580 @default.
- W2113752195 creator A5010644978 @default.
- W2113752195 creator A5017335131 @default.
- W2113752195 creator A5024059956 @default.
- W2113752195 creator A5028701161 @default.
- W2113752195 creator A5036394378 @default.
- W2113752195 creator A5037711521 @default.
- W2113752195 creator A5040021761 @default.
- W2113752195 creator A5040994389 @default.
- W2113752195 creator A5042621361 @default.
- W2113752195 creator A5045517196 @default.
- W2113752195 creator A5051285636 @default.
- W2113752195 creator A5057554279 @default.
- W2113752195 creator A5059173679 @default.
- W2113752195 creator A5066057500 @default.
- W2113752195 creator A5075476949 @default.
- W2113752195 date "2010-02-03" @default.
- W2113752195 modified "2023-10-06" @default.
- W2113752195 title "Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells" @default.
- W2113752195 cites W1492609361 @default.
- W2113752195 cites W1492880054 @default.
- W2113752195 cites W1493021534 @default.
- W2113752195 cites W1534965621 @default.
- W2113752195 cites W1756759934 @default.
- W2113752195 cites W1965615377 @default.
- W2113752195 cites W1965830188 @default.
- W2113752195 cites W1969708590 @default.
- W2113752195 cites W1973154630 @default.
- W2113752195 cites W1982051091 @default.
- W2113752195 cites W1983641075 @default.
- W2113752195 cites W1983940041 @default.
- W2113752195 cites W1985167421 @default.
- W2113752195 cites W1992343552 @default.
- W2113752195 cites W1992514491 @default.
- W2113752195 cites W1992871908 @default.
- W2113752195 cites W1995197301 @default.
- W2113752195 cites W2016185852 @default.
- W2113752195 cites W2022335352 @default.
- W2113752195 cites W2024123171 @default.
- W2113752195 cites W2033734716 @default.
- W2113752195 cites W2034237606 @default.
- W2113752195 cites W2035421116 @default.
- W2113752195 cites W2042797177 @default.
- W2113752195 cites W2050013893 @default.
- W2113752195 cites W2055350603 @default.
- W2113752195 cites W2063280117 @default.
- W2113752195 cites W2078090409 @default.
- W2113752195 cites W2082416593 @default.
- W2113752195 cites W2084878791 @default.
- W2113752195 cites W2087762900 @default.
- W2113752195 cites W2090982381 @default.
- W2113752195 cites W2097192169 @default.
- W2113752195 cites W2110502951 @default.
- W2113752195 cites W2128088040 @default.
- W2113752195 cites W2144309235 @default.
- W2113752195 cites W2145254159 @default.
- W2113752195 cites W2148047805 @default.
- W2113752195 cites W2162700652 @default.
- W2113752195 cites W2164392039 @default.
- W2113752195 cites W2170140374 @default.
- W2113752195 cites W2170846829 @default.
- W2113752195 cites W2172215633 @default.
- W2113752195 cites W227961483 @default.
- W2113752195 cites W68282923 @default.
- W2113752195 doi "https://doi.org/10.1126/scitranslmed.3000349" @default.
- W2113752195 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3005290" @default.
- W2113752195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20371479" @default.
- W2113752195 hasPublicationYear "2010" @default.
- W2113752195 type Work @default.
- W2113752195 sameAs 2113752195 @default.
- W2113752195 citedByCount "353" @default.
- W2113752195 countsByYear W21137521952012 @default.
- W2113752195 countsByYear W21137521952013 @default.
- W2113752195 countsByYear W21137521952014 @default.
- W2113752195 countsByYear W21137521952015 @default.
- W2113752195 countsByYear W21137521952016 @default.
- W2113752195 countsByYear W21137521952017 @default.
- W2113752195 countsByYear W21137521952018 @default.
- W2113752195 countsByYear W21137521952019 @default.
- W2113752195 countsByYear W21137521952020 @default.
- W2113752195 countsByYear W21137521952021 @default.
- W2113752195 countsByYear W21137521952022 @default.
- W2113752195 countsByYear W21137521952023 @default.
- W2113752195 crossrefType "journal-article" @default.
- W2113752195 hasAuthorship W2113752195A5010422580 @default.
- W2113752195 hasAuthorship W2113752195A5010644978 @default.
- W2113752195 hasAuthorship W2113752195A5017335131 @default.
- W2113752195 hasAuthorship W2113752195A5024059956 @default.
- W2113752195 hasAuthorship W2113752195A5028701161 @default.
- W2113752195 hasAuthorship W2113752195A5036394378 @default.
- W2113752195 hasAuthorship W2113752195A5037711521 @default.
- W2113752195 hasAuthorship W2113752195A5040021761 @default.
- W2113752195 hasAuthorship W2113752195A5040994389 @default.
- W2113752195 hasAuthorship W2113752195A5042621361 @default.
- W2113752195 hasAuthorship W2113752195A5045517196 @default.
- W2113752195 hasAuthorship W2113752195A5051285636 @default.
- W2113752195 hasAuthorship W2113752195A5057554279 @default.
- W2113752195 hasAuthorship W2113752195A5059173679 @default.